Board Meeting29 Oct 2026, 03:56 pm
Suven Life Sciences Board Meeting on Nov 5, 2026 for Unaudited Results
AI Summary
Suven Life Sciences Limited has announced a Board of Directors meeting scheduled for November 5, 2026. The primary agenda is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026, on both standalone and consolidated bases. Concurrently, the company has informed that the trading window for its securities will remain closed until 48 hours after the declaration of these financial results, as per the Code of Conduct for Prohibition of Insider Trading.
Key Highlights
- Board meeting scheduled for November 5, 2026.
- To approve unaudited financial results for Q2 FY27.
- Results will be considered on standalone and consolidated basis.
- Trading window closure announced.
- Closure is until 48 hours post results declaration.
Price Impact
More from SUVEN